Antirovirus drugs used for HIV and hepatitis B can significantly reduce the risk of Alzheimer’s disease. This result was reached by researchers from the USA. Results of Scientific Study published Alzheimer’s and Dementia (A & D).
Scientists paid special attention to nucleoside inhibitors of reverse transcriptase (nit). These drugs can suppress inflammatory processes in the body due to intracellular complexes that trigger inflammation – blocking inflammation. Today, chronic neuro buttons are considered one of the main factors in the development of Alzheimer’s disease.
The team analyzed the data from the two largest insurance base: US Veterans Health Control (11 million people) and Marketscan Commercial Base (158 million patients) databases.
The study contained more than 270,000 people over 50 years of age who took NIT but suffered from Alzheimer’s disease at the beginning of the observations. Analysis, age, related diseases, mental health and biochemical indicators, such as many factors.
The results turned out to be encouraging: each year, the therapy reduced the risk of developing Alzheimer’s disease by 4-10%. After correcting the differences between the examined and control groups, this indicator reached 13%, and considering the risk of death, the decline increased up to 37%.
Scientists believe that the next step should believe in additional clinical studies. Researchers plan to check the likelihood of using antiretroviral drugs to prevent or slow Alzheimer’s disease in a wider group of patients.
Previously, scientists To create Missing connection of Parkinson’s and Alzheimer’s Diseases.
What are you thinking?
Source: Gazeta
Barbara Dickson is a seasoned writer for “Social Bites”. She keeps readers informed on the latest news and trends, providing in-depth coverage and analysis on a variety of topics.